HD-OPM Archive
Topics › Low-carb, keto & carnivore

Keto-CTA reanalysis with new software: plaque progression matches the standard diet group

Louis Nervegna · Sep 05, 2025 · ♥ 4 reactions · 3 comments · original Facebook post
Low-carb, keto & carnivorePlaque, CAC & CT angiographyLDL, ApoB & lipid panel
AI summary & key facts

Louis explains that Keto-CTA originally showed 3.8x worse plaque progression than a matched SAD group, and a reanalysis with different software now shows roughly equal progression. He argues this is still a bad result and that both studies must be reanalyzed with the same software for a fair comparison.

The Keto-CTA (LMHR) study showed plaque progression 3.8x worse than in a comparable healthy group eating the standard American diet with normal LDL:

facebook.com/share/v/1FJtCmQdfK

↪ Keto-CTA: metabolic health and large LDL particles gave no protection from plaque

The exact same CT-scanners were used in both groups. And the exact same Cleerly software was used for analysis in both groups. The average age in both groups was the same (55yo), and the principal investigator in both trials was the same (Mathew Budoff).

It was an apples to apples comparison.

————-

Now they have reanalyzed their data using new software. Their result? The progression is roughly equivalent to the progression in the group eating the SAD diet.

This is still a terrible result. One in five people living in the USA eating a SAD diet will have a heart attack in their lifetime.

————-

Of course…

If you are going to re-analyze one study with different software from Cleerly, then you need to re-analyze the other one as well— so you can directly compare them.

Hypothetically: If the results improve by 75% in both studies after using new software, then the ratio of Keto-CTA being 3.8x worse than Nature-CT will not change. It would still show that a carnivore-style keto diet with very high LDL is 3.8x worse than the standard American diet with normal LDL, in terms of plaque progression.

#ketoctareanalysisHD #ketoctaHD

▶Video · YouTube · Dave FeldmanNew KETO-CTA Data - Clarification and Update on CleerlyIn this talk, Dave Feldman shares new updates from the Keto-CTA study, comparing results across four independent CT imaging analyses: Cleerly, QAngio, HeartFlow, and semi-quantitative reads by expert readers. He addresses the controversies around LDL-C, ApoB, plaque progression, and regression, revealing why certain datasets conflict, and presents…youtu.be

Research cited

← newer: People with higher BMI respond less to vitamin D supplementsolder: Taking statins and blood pressure drugs at bedtime has a phy →